Eder patent opposition analysis

The comprehensive analysis of Eder opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Eder

Patent NumberTitleApplicantOpposition DateOpposition Company
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025TEVA PHARMACEUTICALS
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
Method For Producing A Milk-Based Product With Reduced Plasmin-ActivityVALIOAug 18, 2025NUTRICIA
Oat Derived CompositionOATLY ABAug 11, 2025COMPAGNIE GERVAIS DANONE
Novel Cholesterol-Enriched Milk Lipid Composition Suitable For Infant Nutrition, Method Of Production, And Nutritional Compositions Comprising The Milk Lipid CompositionARLA FOODS AMBAAug 6, 2025NUTRICIA
Nanoemulsion For Oral UseNICOVENTURESAug 5, 2025DSM ASSETS
Cannabidiol Preparations And Its UsesGW RESEARCHJul 23, 2025KRAUS & LEDERER PARTGMBB
Compositions For Use In Improving Stool Consistency Or Frequency In Infants Or Young ChildrenNESTECJul 21, 2025NUTRICIA
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025SANDOZ